Global In-Vitro Diagnostics (IVD) Market Analysis & Outlook 2017-2021 Featuring Siemens, Roche Holdings, Abbott Laboratories and Danaher - Research and Markets

DUBLIN--(BUSINESS WIRE)--The "Global
In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook
(2017-2021)"
report has been added to Research and
Markets'
offering.


Growth of the global IVD market is driven by several factors including
rapid occurrence of infectious diseases, increasing diabetic patient
base, and surge in incidences of chronic ailments. Further, growing
geriatric population, rising GDP per capita and increasing healthcare
expenditure per capita will act as a catalyst for market growth.

Owing to the suitable demographical changes and rising disposable income
coupled with improving basic infrastructure, developing regions such as
Asia-Pacific and Latin America are expected to experience robust growth.
However, the market growth prospects could be hindered by lack of
customer adoption, lack of proper facilities and infrastructure and
strict government regulations.

The global IVD market is segmented on the basis of product, technology
used and test location. On the basis of product, this market can be
divided into three sub segments; reagents, analytical instruments and
accessory products. By technologies employed, it can be segmented into
various sub segments; immunochemistry, SMBG, POCT, molecular
diagnostics, clinical chemistry, microbiology, hematology and others.
Further, depending upon test location, the market can be divided into
three sub segments; labs, POC and self-test.

The four major players: Siemens AG., Roche Holdings AG., Abbott
Laboratories and Danaher Corp. are being profiled along with their key
financials and strategies for growth.

Market Dynamics

Growth Drivers

  • Increasing Diabetic Patient Base
  • Rapid Occurrence of Infectious Diseases
  • Surge in Incidences of Chronic Ailments
  • Increasing Global Healthcare Expenditure Per Capita
  • Rising Global GDP per Capita
  • Growing Geriatric Population

Key Trends & Developments

  • Rise in CFDA IVD Market Approvals
  • Consolidation of Core Labs
  • Increasing Penetration of the US LDT Companies in European IVD Market
  • Mergers & Acquisitions

Challenges

  • Lack of Customer Adoption
  • Urgent Need for Proper Infrastructure
  • Government Regulation for IVD Tests

Key Topics Covered:

1. Overview

2. Global IVD Market

3. Global IVD Market Analysis by Technology

4. Regional IVD Market

5. Market Dynamics

6. Competitive Landscape

7. Company Profiles

  • Abbott Laboratories
  • Danaher Corporation
  • Roche Holding AG
  • Siemens AG

For more information about this report visit https://www.researchandmarkets.com/research/5rkj3b/global_invitro


Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: In
Vitro Diagnostics